Stada Arzneimittel
Stada Arzneimittel AG is a pharmaceutical company based in Bad Vilbel, Germany which specializes on a three-pillar strategy consisting of consumer healthcare products (over-the-counter drugs), generics and specialty pharma. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. In 2022, revenue totaled €3.79 billion.
| Company type | Aktiengesellschaft |
|---|---|
| FWB: SAZ | |
| Industry | Pharmaceuticals |
| Founded | Dresden, 1895 |
| Headquarters | , |
Key people | Peter Goldschmidt (CEO),
Simone Berger (CHRO), Miguel Pagan Fernandez (CTO), Boris Döbler (CFO), Günter von Au (Chairman of the supervisory board) |
| Products | Generic, over-the-counter drugs, Specialty Pharmaceuticals |
| Revenue | €3.79 billion (2022) |
Number of employees | 13,183 (FTE, as of December 31, 2022) |
| Website | www.stada.com |
Commonly known products produced by Stada are Stada-brand acetaminophen and lactulose, Grippostad-C cold medicine and Ladival sun protection products. Stada is involved in various charity projects and sponsoring activities which include the support for dolphin aid e.V since 2007 and the support of a Romanian children's village in Timișoara.